Viome unveils at-home oral, throat cancer detection test

$ 21.50

4.9 (476) In stock

At-home diagnostics startup Viome Life Sciences has launched a new test to help detect oral and throat cancers. | The test relies on Viome’s proprietary RNA sequencing technology and AI to measure gene expression of the oral microbiome and human cells in each patient’s saliva, which are used to identify early biomarkers associated with oral and throat cancers.

Viome unveils at-home oral, throat cancer detection test